Scientific Papers
OriGene scientists are dedicated to the advancement of biological and medical science. They attend scientific conferences and share their ideas and findings with fellow scientists.
PEGS 2023
| Target of Interest | Title | View PDF |
|---|---|---|
| PSCA | PSCA Expressions in Cancers: A Potential Prognostic Marker and Target for Immunotherapy. |
2023 American Association of Cancer Research
| Target of Interest | Title | View PDF |
|---|---|---|
| MAGEA3 & MAGEA4 | MAGEA3 and MAGEA4 proteins show co-expression in lung, bladder and colon cancer. | |
| Inducible vectors | A new generation of inducible all-in-one Tet-On-ORF/shRNA vectors | |
| MAGEA3 | MAGE-A3 expression with MMR-MSH6 screening suggests MAGE-A3 as a potential target for microsatellite-stable colorectal cancer. | |
| MAGEA3 & MAGEA4 | Colocalization of MAGE-A3 and MAGE-A4 in bladder cancer. |
2022 National Society for Histotechnology
| Target of Interest | Title | View PDF |
|---|---|---|
| MAGEA3 and MAGEA4 | MAGEA3 and MAGEA4 have different expression pattern in lung cancer |
2022 American Association for Clinical Chemistry Meeting
| Target of Interest | Title | View PDF |
|---|---|---|
| MAGE-A3 | Serum MAGE-A3 Is A Potential Prognostic Marker for Prostate Cancer |
2022 American Association of Cancer Research Annual Meeting
| Target of Interest | Title | View PDF |
|---|---|---|
| MAGE | A renewable IHC control tool CytoSection for defining MAGEA3, MAGEA4, and MAGEA9 antibody specificity | |
| HSD17B13 | Overexpression of HSD17B13 induced G1 arrest in hepatic cell lines detected by anti-HSD17B13 recombinant rabbit monoclonal antibody |
2020 American Association of Cancer Research Virtual Annual Meeting
| Target of Interest | Title | View PDF |
|---|---|---|
| PD-L1 | PD-L1 and Diacylglycerol Kinase alpha (DGKa) Expression in NSCLC and Bladder Cancer |
2019 American Association of Cancer Research Annual Meeting
| Target of Interest | Title | View PDF |
|---|---|---|
| CRISPR | CRISPR KN2.0: A Universal Solution for Genome-Wide Gene Knockout/Knockin | |
| PD-L1 | Immune Cell Expression of LAG3 and TIM3 In The Tumor Micro Environment Of PD-L1 Positive/Negative Bladder Cancer, Melanoma, And Lung Cancer |
2018 American Association of Cancer Research Annual Meeting
| Target of Interest | Title | View PDF |
|---|---|---|
| PD-L1 | Characterization of Two New Recombinant Rabbit anti-PDL1 Antibodies In Bladder Cancer, NSCLC, and Melanoma With Immune Cell Markers CD3, CD8A, CD20, CD68 and FOXP3 |
2016 American Association of Cancer Research Annual Meeting
| Target of Interest | Title | View PDF |
|---|---|---|
| ALK | A new, highly sensitive ALK antibody improves the screening of rearranged-ALK by IHC | |
| LGR5 | Evaluation of LGR5 protein expression in colon cancer stem cells | |
| HER2 | A screen of breast and colon cancers with HER2 antibody clone UMAB36 does not exhibit the cross-reactivity of clone 4B5 with HER4 protein |
2015 American Association of Cancer Research Annual Meeting
| Target of Interest | Title | View PDF |
|---|---|---|
| ALK | The development of a highly sensitive mouse monoclonal antibody for screening ALK-rearrangements in lung cancers | |
| HER2 | Develop a Highly Specific HER2 Antibody for IHC Screening in Breast and Gastric Cancers | |
| Ki67 | The Development of a Highly Specific IHC Monoclonal Antibody against Ki-67 | |
| MET | The development of a highly specific mouse monoclonal MET antibody for IHC application |
2015 Experimental Biology
| Target of Interest | Title | View PDF |
|---|---|---|
| LGR5 | The Development and Evaluation of Highly Specific Monoclonal Antibodies against Human LGR5 | |
| PD-1 | The Development of an Anti-PD1 Mono-Specific Antibody (UMAB199) for Anatomic Pathology |
Germany
Japan
United Kingdom
China